SUV39H1 Antibody

What applications are SUV39H1 antibodies validated for?

SUV39H1 antibodies have been validated for multiple applications in molecular and cellular biology research:

For optimal results, always perform antibody titration in your specific experimental system as reactivity may vary across sample types and experimental conditions .

What is the expected molecular weight of SUV39H1 in Western blot analysis?

When performing Western blot analysis, SUV39H1 typically appears at 48-50 kDa. The calculated molecular weight is 48 kDa, but post-translational modifications may cause slight variations in migration patterns. SUV39H1 has two reported isoforms with molecular weights of 48 and 49 kDa, which may appear as closely migrating bands depending on gel resolution .

For optimal detection:

• Use freshly prepared samples with protease inhibitors

• Load 20-40 μg of total protein per lane

• Use 10% SDS-PAGE gels for optimal resolution

• Transfer to PVDF membranes for stronger signal intensity

How should SUV39H1 antibodies be stored to maintain reactivity?

Proper storage is critical for maintaining antibody performance:

• Store at -20°C in aliquots to avoid freeze-thaw cycles

• Most commercial SUV39H1 antibodies are supplied in PBS with 0.02% sodium azide and 50% glycerol at pH 7.3

• Antibodies remain stable for at least one year at -20°C when properly stored

• For antibodies supplied in small volumes (e.g., 20 μl), aliquoting may be unnecessary

• Some formulations contain 0.1% BSA as a stabilizer

Note that sodium azide is highly toxic and should be handled with appropriate safety precautions .

How can I validate the specificity of my SUV39H1 antibody?

Rigorous validation is essential before using any SUV39H1 antibody for experimental purposes:

• Perform Western blot analysis using positive controls:

  • Verified cell lines known to express SUV39H1 (HCT 116, HEK-293, HeLa, HepG2, C6, NIH/3T3 cells)

  • Compare with negative controls using SUV39H1 knockout/knockdown samples

• Confirm specificity using orthogonal approaches:

  • Competition assays with recombinant SUV39H1 protein

  • Immunoprecipitation followed by mass spectrometry

  • Parallel analysis with at least two different SUV39H1 antibodies recognizing distinct epitopes

• Verify cross-reactivity with SUV39H2 (paralog):

  • SUV39H1 and SUV39H2 share sequence homology

  • Use SUV39H2-specific antibodies as controls to ensure specificity

How should SUV39H1 antibodies be optimized for chromatin immunoprecipitation (ChIP) experiments?

ChIP experiments with SUV39H1 require careful optimization:

• Crosslinking optimization: As SUV39H1 interacts with both histones and DNA, dual crosslinking with formaldehyde (1%, 10 min) followed by disuccinimidyl glutarate (DSG, 2 mM, 30 min) may improve capture efficiency.

• Chromatin shearing: Target 200-500 bp fragments using:

  • Sonication: Optimize cycle number and amplitude based on cell type

  • Enzymatic digestion: May preserve protein integrity better than sonication

• Antibody selection and validation:

  • Choose antibodies that specifically recognize the native protein conformation

  • Validate using IP-Western blot before ChIP experiments

  • Pre-clear lysates to reduce background

• Controls:

  • Include SUV39H1-depleted cells as negative controls

  • Use H3K9me3 ChIP as a positive control for SUV39H1 target regions

  • Include IgG controls to establish background signal levels

When analyzing results, focus on heterochromatic regions, particularly at pericentric repeats and telomeres, where SUV39H1 is known to establish H3K9me3 marks .

What is the role of SUV39H1 in host defense against mycobacterial infections, and how can this be studied?

SUV39H1 plays a novel role in host defense against mycobacterial infection:

• Infection response mechanism:

  • Upon mycobacterial infection, SUV39H1 expression increases specifically in infected macrophages

  • SUV39H1 translocates from the nucleus to the cytoplasm and associates with mycobacterial bacilli

  • It binds to and trimethylates mycobacterial histone-like protein HupB on 'Lys-140'

  • This methylation reduces bacterial cell adhesion capability and biofilm formation

• Experimental approaches to study this phenomenon:

  • Bacterial binding assay: Incubate SFB-tagged SUV39H1 with mycobacteria in vitro, wash extensively, and analyze bound proteins by Western blot

  • Immunofluorescence microscopy: Visualize co-localization of SUV39H1 with intracellular mycobacteria

  • Phagosome isolation: Isolate phagosomes from infected macrophages using sucrose gradient centrifugation and analyze for SUV39H1 presence

  • Bacterial survival assays: Compare bacterial survival in wild-type vs. SUV39H1-depleted macrophages

  • Murine infection models: Evaluate infection outcomes in SUV39H1-deficient mice

Importantly, SUV39H1 but not its paralog SUV39H2 is involved in this defense mechanism, highlighting the specific role of SUV39H1 in antimycobacterial response .

How does SUV39H1 contribute to the oxidative phosphorylation (OXPHOS) pathway in cancer, and what techniques can be used to investigate this?

SUV39H1 has recently been identified as a regulator of the OXPHOS pathway in hepatocellular carcinoma:

• Role in metabolic reprogramming:

  • SUV39H1 overexpression upregulates genes involved in the OXPHOS pathway

  • Increases ATP production in hepatoma cells

  • Promotes proliferation and migration of hepatoma cells through OXPHOS pathway modulation

  • This effect can be reversed using OXPHOS inhibitors (Rotenone, Oligomycin)

• Methodological approaches to study this function:

  a) Transcriptome analysis:

  • RNA-seq to identify OXPHOS genes regulated by SUV39H1

  • Compare gene expression profiles between SUV39H1-overexpressing and control cells

  b) Metabolic analyses:

  • ATP production assays

  • Oxygen consumption rate (OCR) measurements

  • Extracellular acidification rate (ECAR) analysis

  c) Functional validation:

  • Use OXPHOS inhibitors to reverse SUV39H1-mediated effects

  • Combined SUV39H1 overexpression with knockdown of specific OXPHOS components

  d) Clinical correlation:

  • Analyze patient samples for SUV39H1 expression and OXPHOS activity

  • Correlate findings with clinical parameters and survival data

This newly discovered role makes SUV39H1 a potential therapeutic target in HCC, particularly in HBV-associated cases.

What technical considerations are important when using SUV39H1 antibodies for detecting the protein in clinical samples?

Using SUV39H1 antibodies for clinical applications requires special attention to several factors:

• Sample preparation:

  • For serum samples: Use standardized collection and processing protocols to minimize pre-analytical variables

  • For tissue samples: Consider fixation method impact on epitope accessibility (FFPE vs. frozen)

• Detection methods:

  • ELISA: Can detect soluble SUV39H1 in serum samples with high sensitivity

  • Immunohistochemistry: Requires optimization of antigen retrieval methods

  • Western blot: Better for semi-quantitative analysis in tissue lysates

• Clinical validation considerations:

  • Establish reference ranges using sufficient healthy controls

  • Account for demographic variables (age, sex, etc.)

  • Use statistical approaches to determine diagnostic thresholds

• Case study with HBV-HCC biomarker application:

  • In a study with 35 healthy controls, 34 CHB patients, and 27 HBV-HCC patients:

    • SUV39H1 levels were higher in CHB patients than healthy controls

    • SUV39H1 levels were higher in HBV-HCC patients than in CHB patients

    • Combined with alpha-fetoprotein (AFP), SUV39H1 improved diagnostic accuracy

    • Correlations with liver function indicators (ALT, AST, γ-GT) should be analyzed

These considerations are essential when developing SUV39H1 as a diagnostic biomarker for clinical applications.

How can researchers distinguish between SUV39H1 and its paralog SUV39H2 in experimental settings?

Distinguishing between these closely related paralogs requires careful experimental design:

• Antibody selection:

  • Use antibodies targeting non-conserved regions:

    • SUV39H1 antibodies targeting N-terminal regions (amino acids 1-126) show minimal cross-reactivity

    • Validate antibody specificity using overexpression systems for both proteins

    • Confirm using knockout/knockdown controls for each paralog individually

• Expression pattern analysis:

  • Unlike SUV39H1, SUV39H2 expression doesn't change during mycobacterial infection

  • SUV39H2 shows more tissue-specific expression patterns

  • SUV39H1 localizes to cell membranes during mycobacterial infection, while SUV39H2 does not

• Functional assays to highlight differences:

  • Analyze subcellular distribution patterns under various stimuli

  • Perform rescue experiments in knockout backgrounds

  • Compare methyltransferase activity against specific substrates

• Detection by mass spectrometry:

  • Identify paralog-specific peptides for unambiguous identification

  • Use parallel reaction monitoring (PRM) for targeted quantification

Understanding the distinct functions of these paralogs is crucial as they may have complementary or competitive roles in various biological processes .

What are the critical factors for successfully detecting SUV39H1-mediated histone modifications?

To effectively detect SUV39H1-mediated histone modifications (primarily H3K9me3):

• Antibody selection for H3K9me3 detection:

  • Choose highly specific antibodies that distinguish H3K9me3 from other methylation states (H3K9me1, H3K9me2)

  • Validate using peptide competition assays and modified histone standards

  • Consider using multiple antibodies from different suppliers to confirm findings

• Sample preparation considerations:

  • Use fresh samples whenever possible

  • Include histone deacetylase inhibitors during extraction to preserve modification patterns

  • For Western blots, acid extraction methods improve histone purification

• Controls and normalization:

  • Use recombinant histones with defined modifications as positive controls

  • Include SUV39H1/2 double knockout samples as negative controls

  • Normalize to total H3 levels rather than housekeeping proteins

• Advanced detection approaches:

  • ChIP-seq for genome-wide profiling of H3K9me3 distribution

  • Mass spectrometry for quantitative analysis of histone modifications

  • Immunofluorescence microscopy to visualize nuclear distribution patterns

• Data interpretation challenges:

  • H3K9me3 can be deposited by multiple enzymes (not only SUV39H1)

  • Consider redundancy between SUV39H1 and SUV39H2

  • The pattern and intensity of H3K9me3 marks vary by cell type and physiological state

Careful attention to these factors ensures accurate detection and interpretation of SUV39H1-mediated histone modifications.